VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES
Japan
2019-537752
Filed on 2019-03-22
2019-537752
Filed on 2019-03-22
VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES
India
201917015489
Filed on 2017-09-22
201917015489
Filed on 2017-09-22
VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES
European Patent
17778443.6
Filed on 2019-04-17
17778443.6
Filed on 2019-04-17
VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES
Australia
2017332789
Filed on 2019-04-17
2017332789
Filed on 2019-04-17
Chimpanzee Adenoviral Vector-Based Filovirus Vaccines
Turkey
11769662.5
Filed on 2011-04-15
11769662.5
Filed on 2011-04-15
Chimpanzee Adenoviral Vector-Based Filovirus Vaccines
The Netherlands
11769662.5
Filed on 2011-04-15
11769662.5
Filed on 2011-04-15
Chimpanzee Adenoviral Vector-Based Filovirus Vaccines
Italy
11769662.5
Filed on 2011-04-15
11769662.5
Filed on 2011-04-15
Chimpanzee Adenoviral Vector-Based Filovirus Vaccines
Ireland
11769662.5
Filed on 2011-04-15
11769662.5
Filed on 2011-04-15
Chimpanzee Adenoviral Vector-Based Filovirus Vaccines
United Kingdom
11769662.5
Filed on 2011-04-15
11769662.5
Filed on 2011-04-15
Chimpanzee Adenoviral Vector-Based Filovirus Vaccines
France
11769662.5
Filed on 2011-04-15
11769662.5
Filed on 2011-04-15